2/5
06:10 am
neup
Neuphoria Therapeutics (NASDAQ:NEUP) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
Neuphoria Therapeutics (NASDAQ:NEUP) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
12/10
07:18 am
neup
Neuphoria Therapeutics (NASDAQ:NEUP) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Medium
Report
Neuphoria Therapeutics (NASDAQ:NEUP) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
12/8
08:00 am
neup
Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria’s Director Nominees
Medium
Report
Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria’s Director Nominees